Long‐term results of concurrent chemoradiotherapy using cisplatin and vinorelbine for stage III non‐small‐cell lung cancer
H Horinouchi, I Sekine, M Sumi, K Noda… - Cancer …, 2013 - Wiley Online Library
Concurrent chemoradiotherapy is the standard treatment for unresectable stage III non‐
small cell lung cancer (NSCLC). The long‐term feasibility and efficacy of vinorelbine and …
small cell lung cancer (NSCLC). The long‐term feasibility and efficacy of vinorelbine and …
[引用][C] Long-term results of concurrent chemoradiotherapy using cisplatin and vinorelbine for stage III non-small-cell lung cancer
H Horinouchi, I Sekine, M Sumi, K Noda, K Goto… - Cancer Science, 2012 - cir.nii.ac.jp
Long-term results of concurrent chemoradiotherapy using cisplatin and vinorelbine for stage III
non-small-cell lung cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
non-small-cell lung cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
[HTML][HTML] Long‐term results of concurrent chemoradiotherapy using cisplatin and vinorelbine for stage III non‐small‐cell lung cancer
H Horinouchi, I Sekine, M Sumi, K Noda, K Goto… - Cancer …, 2013 - ncbi.nlm.nih.gov
Concurrent chemoradiotherapy is the standard treatment for unresectable stage III non‐
small cell lung cancer (NSCLC). The long‐term feasibility and efficacy of vinorelbine and …
small cell lung cancer (NSCLC). The long‐term feasibility and efficacy of vinorelbine and …
Long‐term results of concurrent chemoradiotherapy using cisplatin and vinorelbine for stage III non‐small‐cell lung cancer
H Horinouchi, I Sekine, M Sumi, K Noda, K Goto, K Mori… - Cancer Science, 2013 - infona.pl
Concurrent chemoradiotherapy is the standard treatment for unresectable stage III non‐
small cell lung cancer (NSCLC). The long‐term feasibility and efficacy of vinorelbine and …
small cell lung cancer (NSCLC). The long‐term feasibility and efficacy of vinorelbine and …
[PDF][PDF] Long-term results of concurrent chemoradiotherapy using cisplatin and vinorelbine for stage III non-small-cell lung cancer
H Horinouchi, I Sekine, M Sumi, K Noda, K Goto, K Mori… - Cancer Sci, 2013 - academia.edu
Materials and Methods Study selection. Two previous studies were included in this analysis.
One was a phase I study of concurrent thoracic radiotherapy with cisplatin plus vinorelbine …
One was a phase I study of concurrent thoracic radiotherapy with cisplatin plus vinorelbine …
Long-term results of concurrent chemoradiotherapy using cisplatin and vinorelbine for stage III non-small-cell lung cancer.
H Horinouchi, I Sekine, M Sumi, K Noda, K Goto… - Cancer …, 2012 - europepmc.org
Concurrent chemoradiotherapy is the standard treatment for unresectable stage III non‐
small cell lung cancer (NSCLC). The long‐term feasibility and efficacy of vinorelbine and …
small cell lung cancer (NSCLC). The long‐term feasibility and efficacy of vinorelbine and …
Long-term results of concurrent chemoradiotherapy using cisplatin and vinorelbine for stage III non-small-cell lung cancer
H Horinouchi, I Sekine, M Sumi, K Noda… - Cancer …, 2013 - pubmed.ncbi.nlm.nih.gov
Concurrent chemoradiotherapy is the standard treatment for unresectable stage III non-small
cell lung cancer (NSCLC). The long-term feasibility and efficacy of vinorelbine and cisplatin …
cell lung cancer (NSCLC). The long-term feasibility and efficacy of vinorelbine and cisplatin …